Universidad de Caldas Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2014
NCT02299908
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Patricia Salazar Villegas | Universidad de Caldas

Active Ingredients

Drugs in Phase 4 Trials (1)

levobupivacaine (chirocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1